Structure Info
- Chemspace ID
- CSCS06902869230 (Synthesis)
- IUPAC Name
- (10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-[4-hydroxy-3-(²H₃)methoxy-5-methoxyphenyl]-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-trien-12-one
- Mol formula
- C29H32O13
- Mol weight
- 592 Da
- Catalog Number(s)
- 26488, HY-13629S
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.16
- Heavy atoms count
- 42
- Rotatable bond count
- 5
- Number of rings
- 7
- Carbon bond saturation, Fsp3
- 0.551
- Polar surface area (Å)
- 161
- Hydrogen bond acceptors count
- 12
- Hydrogen bond donors count
- 3
- Zoom the structure
- CSCS06902869230
Items Overall 2 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress | TBD | United States To: | 90 | 1 mg | POA | |
Description: Names: Etoposide-d3; VP-16-d3; VP-16-213-d3; Product Description: Etoposide-d3 (VP-16-d3) is the deuterium labeled Etoposide (HY-13629). Etoposide (VP-16) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II , thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .; Target: Antibiotic;Apoptosis;Autophagy;Bacterial;Isotope-Labeled Compounds;Mitophagy;Topoisomerase | ||||||
| MedChemExpress EU | TBD | Sweden To: | 90 | 1 mg | POA | |
Description: Names: Etoposide-d3; VP-16-d3; VP-16-213-d3; Product Description: Etoposide-d3 (VP-16-d3) is the deuterium labeled Etoposide (HY-13629). Etoposide (VP-16) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy; Target: Antibiotic;Apoptosis;Autophagy;Bacterial;Isotope-Labeled Compounds;Mitophagy;Topoisomerase | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire